FDA to review Inspire Medical's sleep apnea implant

January 8, 2014 by Arezu Sarvestani

Medtronic spin-out Inspire Medical Systems will next month undergo FDA advisory panel review for its implantable Inspire II Upper Airway Stimulator for treatment of obstructive sleep apnea.

Inspire Medical lands a date with the FDA for implanted sleep apnea device

Inspire Medical Systems is getting the FDA treatment, landing a date next month with the Anesthesiology & Respiratory Therapy Devices panel to undergo review of the company's implanted Inspire II Upper Airway Stimulator for treatment of obstructive sleep apnea.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp